Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | MD Pediatrix Medical Group, Inc. | ABBV AbbVie |
|---|---|---|
| Price | $25.93 +1.7% | $263.96 -0.0% |
| StockIQ Score | 58C Moderate Risk: Medium | 59C Moderate Risk: High |
| Technical | 50C- | 88A |
| Fundamental | 63C+ | 57C |
| Growth | 60C+ | 34F |
| Fair Value | 55C | 33F |
| News | 68B- | 100A+ |
| Quality | 58C | 42D |
| Risk | 56C | 36F |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Both stocks have a moderate rating, with AbbVie (ABBV) scoring 59 on the investor metric versus 58 for Pediatrix (MD). AbbVie leads strongly on technical score (88 vs 50) and edges higher in investor score. Pediatrix outperforms in fundamental (63 vs 57), growth (60 vs 34), and valuation (55 vs 33).
